MAPT and Alzheimer disease: The plasma levels of phosphorylated tau (p-tau) 181 are elevated in AD (10), whereas the plasma levels of neurofilament light chain protein (NFL) are elevated in both AD and FTLD (11), although the levels are higher in FTLD (12).